BiotechTube
Home/Sapience Therapeutics/Abi Vainstein-Haras, M.D.
AV

Abi Vainstein-Haras, M.D.

Chief Medical Officer

Sapience Therapeutics

Therapeutic Areas

Oncology

Sapience Therapeutics Pipeline

DrugIndicationPhase
Lucicebtide (ST101)Glioblastoma (GBM)Phase 2
ST316Advanced Solid Tumors, Colorectal Cancer, Familial Adenomatous Polyposis (FAP)Phase 2